1-1 of 1
Berna Evranos, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Amplitude of Response, Early Mobilization (M) and Pre-Autologous Transplant (ASCT) Use of Bortezomib (V) and/or Thalidomide (T) Are Predictors of Longer Progression Free (PFS) and/or Overall Survival (OS) in Myeloma.

Meral Beksac, MD, Ender Soydan, MD, Vildan Ozkocaman, MD, Pervin Topcuoglu, MD, Berna Evranos, MD, Merih Kizil, MD, Aynur U. Bilgin, MD, Mutlu Arat, MD, Muhit Ozcan, MD, Onder Arslan, MD, Gunhan Gurman, MD, Osman Ilhan, MD
Journal: Blood
Blood (2007) 110 (11): 5096.
https://doi.org/10.1182/blood.V110.11.5096.5096
Published: 2007